Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

First do no harm: a real need to deprescribe in older patients

- Featured Image

We enthusiastically welcome Scott and colleagues’ article highlighting the real need to deprescribe in older patients;1 however, we would like to emphasise the role of validated tools and medication management reviews in deprescribing.

Validated tools help clinicians identify potentially inappropriate medications. Scott et al state that medications whose benefits are outweighed by harm in most circumstances, such as potent opioids, anticholinergics and benzodiazepines, account for relatively few adverse drug events (ADEs) in Australian practice. This is potentially misleading, as it relies on practitioners or consumers recognising ADEs. Recognising ADEs is relatively simple when anticoagulants cause bleeding, but more subtle ADEs, such as functional impairment from anticholinergic and sedative medications, are often not recognised and are misattributed to ageing or multimorbidity. Therefore, validated tools for recognising high-risk medicines are an important component of medication management reviews.

We agree that input from appropriately trained (accredited) pharmacists and other health care professionals with expertise in the clinical use of medicines has been shown to be beneficial for deprescribing practice. We wish to highlight the value of medication management reviews, such as Home Medicines Review (HMR) and Residential Medication Management Review (RMMR), which involve pharmacists and general…

email